Genetic Variation in Cholesterol Ester Transfer Protein, Serum CETP Activity, and Coronary Artery Disease Risk in Asian Indian Diabetic Cohort

Overview

Journal Pharmacogenet Genomics

Specialties Genetics
Pharmacology

Date 2011 Dec 7

PMID 22143414

Citations 22

Authors

Ashley Schierer

Latonya F Been

Sarju Ralhan

Gurpreet S Wander

Christopher E Aston

Dharambir K Sanghera

Affiliations

Soon will be listed here.

Abstract

Background: The role of cholesteryl ester transfer protein (CETP) in the metabolism of high-density lipoprotein cholesterol (HDL-C) is well studied but still controversial. More recently, genome-wide association studies and meta-analyses reported the association of a promoter variant (rs3764261) with HDL-C in Caucasians and other ethnic groups. In this study, we have examined the role of genetic variation in the promoter region of CETP with HDL-C, CETP activity, coronary artery disease (CAD), CAD risk factors, and the interaction of genetic factors with environment in a unique diabetic cohort of Asian Indian Sikhs.

Methods And Results: We genotyped four variants; three tagging single nucleotide polymorphisms from promoter (rs3764261, rs12447924, rs4783961) and one intronic variant (rs708272 Taq1B) on 2431 individuals from the Sikh Diabetes study. Two variants (rs3764261 and rs708272) exhibited a strong association with HDL-C in both normoglycemic controls (β=0.12; P=9.35×10 for rs3764261; β=0.10, P=0.002 for rs708272) and diabetic cases (β=0.07, P=0.016 for rs3764261; β=0.08, P=0.005 for rs708272) with increased levels among minor homozygous 'AA' carriers. In addition, the same 'A' allele carriers in rs3764261 showed a significant decrease in systolic blood pressure (β=-0.08, P=0.002) in normoglycemic controls. Haplotype analysis of rs3764261, rs12447924, rs4783961, and rs708272 further revealed a significant association of 'ATAA' haplotype with an increased HDL-C (β=2.71, P=6.38×10) and 'CTAG' haplotype with decreased HDL-C levels (β=-1.78, P=2.5×10). Although there was no direct association of CETP activity and CETP polymorphisms, low CETP activity was associated with an increased risk to CAD (age, BMI, and sex-adjusted odds ratio=2.2; 95% confidence interval: 1.4-3.4; P=0.001) in this study. Our data revealed a strong interaction of rs3764261 and rs708272 for affecting the association between CETP activity and HDL-C levels (P=2.2×10 and P=4.4×10, respectively).

Conclusion: Our results, in conjunction with earlier reports confirm low CETP activity to be associated with higher CAD risk. Although there was no direct association of CETP activity with CETP polymorphisms, our findings revealed a significant interaction between CETP variants and CETP activity for affecting HDL-C levels. These results urge a deeper evaluation of the individual genetic variation in the CETP before implementing pharmaceutical intervention of blocking CETP for preventing CAD events.

Citing Articles

Association of Gene Polymorphisms and Haplotypes with Acute Heart Rate Response to Exercise.

Al Ashkar H, Kovacs N, Veres-Balajti I, Adany R, Piko P Int J Mol Sci. 2024; 25(16).

PMID: 39201274 PMC: 11354538. DOI: 10.3390/ijms25168587.

Gender Differences in the Association between Cholesteryl Esters Transfer Protein Polymorphism (rs708272) and Plasma Lipid Levels in Hyperlipidaemic Participants at Hospital Universiti Sains Malaysia.

Shamsudin A, Bakar N Malays J Med Sci. 2023; 30(2):96-110.

PMID: 37102051 PMC: 10125239. DOI: 10.21315/mjms2023.30.2.9.

Autoimmune Reaction Associated With Long COVID Syndrome and Cardiovascular Disease: A Genetic Case Report.

Safronenka A, Capcha J, Webster K, Buglo E, Tamariz L, Goldberger J JACC Case Rep. 2022; 6:101644.

PMID: 36348978 PMC: 9633038. DOI: 10.1016/j.jaccas.2022.09.014.

Ethnic differences in ApoC-III concentration and the risk of cardiovascular disease: No evidence for the cardioprotective role of rare/loss of function variants in non-Europeans.

Rout M, Lerner M, Blackett P, Peyton M, Stavrakis S, Sidorov E Am Heart J Plus. 2022; 13.

PMID: 35528316 PMC: 9075110. DOI: 10.1016/j.ahjo.2022.100128.

Mendelian Randomization of Dyslipidemia on Cognitive Impairment Among Older Americans.

Fu M, Bakulski K, Higgins C, Ware E Front Neurol. 2021; 12:660212.

PMID: 34248819 PMC: 8260932. DOI: 10.3389/fneur.2021.660212.

References

Libby P . The forgotten majority: unfinished business in cardiovascular risk reduction. J Am Coll Cardiol. 2005; 46(7):1225-8. DOI: 10.1016/j.jacc.2005.07.006. View

Sanghera D, Demirci F, Been L, Ortega L, Ralhan S, Wander G . PPARG and ADIPOQ gene polymorphisms increase type 2 diabetes mellitus risk in Asian Indian Sikhs: Pro12Ala still remains as the strongest predictor. Metabolism. 2009; 59(4):492-501. PMC: 2843807. DOI: 10.1016/j.metabol.2009.07.043. View

Snieder H, van Doornen L, Boomsma D . Dissecting the genetic architecture of lipids, lipoproteins, and apolipoproteins: lessons from twin studies. Arterioscler Thromb Vasc Biol. 1999; 19(12):2826-34. DOI: 10.1161/01.atv.19.12.2826. View

McTaggart F, Jones P . Effects of statins on high-density lipoproteins: a potential contribution to cardiovascular benefit. Cardiovasc Drugs Ther. 2008; 22(4):321-38. PMC: 2493531. DOI: 10.1007/s10557-008-6113-z. View

Cannon C, Shah S, Dansky H, Davidson M, Brinton E, Gotto A . Safety of anacetrapib in patients with or at high risk for coronary heart disease. N Engl J Med. 2010; 363(25):2406-15. DOI: 10.1056/NEJMoa1009744. View

Pascot A, Lemieux I, Bergeron J, Tremblay A, Nadeau A, Prudhomme D . HDL particle size: a marker of the gender difference in the metabolic risk profile. Atherosclerosis. 2002; 160(2):399-406. DOI: 10.1016/s0021-9150(01)00579-2. View

Sanghera D, Bhatti J, Bhatti G, Ralhan S, Wander G, Singh J . The Khatri Sikh Diabetes Study (SDS): study design, methodology, sample collection, and initial results. Hum Biol. 2006; 78(1):43-63. DOI: 10.1353/hub.2006.0027. View

Vasan R, Pencina M, Robins S, Zachariah J, Kaur G, DAgostino R . Association of circulating cholesteryl ester transfer protein activity with incidence of cardiovascular disease in the community. Circulation. 2009; 120(24):2414-20. PMC: 2818786. DOI: 10.1161/CIRCULATIONAHA.109.872705. View

Rossouw J . Hormones, genetic factors, and gender differences in cardiovascular disease. Cardiovasc Res. 2002; 53(3):550-7. DOI: 10.1016/s0008-6363(01)00478-3. View

10.

Bruce C, Sharp D, Tall A . Relationship of HDL and coronary heart disease to a common amino acid polymorphism in the cholesteryl ester transfer protein in men with and without hypertriglyceridemia. J Lipid Res. 1998; 39(5):1071-8. View

11.

Hassanzadeh T, Firoozrai M, Zonouz A, Zavarehee A, Paoli M . Taq1B polymorphism of cholesteryl ester transfer protein (CETP) gene in primary combined hyperlipidaemia. Indian J Med Res. 2009; 129(3):293-8. View

12.

Freeman D, Griffin B, Holmes A, Lindsay G, Gaffney D, Packard C . Regulation of plasma HDL cholesterol and subfraction distribution by genetic and environmental factors. Associations between the TaqI B RFLP in the CETP gene and smoking and obesity. Arterioscler Thromb. 1994; 14(3):336-44. DOI: 10.1161/01.atv.14.3.336. View

13.

Sanghera D, Been L, Ralhan S, Wander G, Mehra N, Singh J . Genome-wide linkage scan to identify loci associated with type 2 diabetes and blood lipid phenotypes in the Sikh Diabetes Study. PLoS One. 2011; 6(6):e21188. PMC: 3116872. DOI: 10.1371/journal.pone.0021188. View

14.

Sandhofer A, Tatarczyk T, Laimer M, Ritsch A, Kaser S, Paulweber B . The Taq1B-variant in the cholesteryl ester-transfer protein gene and the risk of metabolic syndrome. Obesity (Silver Spring). 2008; 16(4):919-22. DOI: 10.1038/oby.2007.130. View

15.

Poss J, Custodis F, Werner C, Weingartner O, Bohm M, Laufs U . Cardiovascular disease and dyslipidemia: beyond LDL. Curr Pharm Des. 2011; 17(9):861-70. DOI: 10.2174/138161211795428858. View

16.

Agerholm-Larsen B, Nordestgaard B, Steffensen R, Jensen G, Tybjaerg-Hansen A . Elevated HDL cholesterol is a risk factor for ischemic heart disease in white women when caused by a common mutation in the cholesteryl ester transfer protein gene. Circulation. 2000; 101(16):1907-12. DOI: 10.1161/01.cir.101.16.1907. View

17.

Halldorsson B, Istrail S, De La Vega F . Optimal selection of SNP markers for disease association studies. Hum Hered. 2005; 58(3-4):190-202. DOI: 10.1159/000083546. View

18.

. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2003; 27 Suppl 1:S5-S10. DOI: 10.2337/diacare.27.2007.s5. View

19.

Thompson A, Di Angelantonio E, Sarwar N, Erqou S, Saleheen D, Dullaart R . Association of cholesteryl ester transfer protein genotypes with CETP mass and activity, lipid levels, and coronary risk. JAMA. 2008; 299(23):2777-88. DOI: 10.1001/jama.299.23.2777. View

20.

Purcell S, Cherny S, Sham P . Genetic Power Calculator: design of linkage and association genetic mapping studies of complex traits. Bioinformatics. 2002; 19(1):149-50. DOI: 10.1093/bioinformatics/19.1.149. View